Phytochemistry of Plants of Genus Cassia by Kumar, Brijesh

Phytochemistry of Plants of Genus Cassia (Hardcover) (ISBN-13: 9781032030210)

Vendor: Brijesh Kumar
Product type: Books
Format: Hardcover
$68.99
$68.99
$68.99
Subtotal: $68.99
Phytochemistry of Plants of Genus Cassia by Kumar, Brijesh

Phytochemistry of Plants of Genus Cassia

$68.99
Phytochemistry of Plants of Genus Cassia by Kumar, Brijesh

Phytochemistry of Plants of Genus Cassia

$68.99
Format: Hardcover
Description
Description
x

Cassia is an indigenous plant in Africa, Latin America, Northern Australia and Southeast Asia. Several Cassia species are of high commercial and medicinal significance since they are used as spices and in traditional medicines. Currently plants from genus Cassia is in great demand due to their immense medicinal properties. Cassia species have various pharmacological activities such as antibacterial, analgesic, antiinflammatory, antiarthritic, hepatoprotective, antitumor, antifertility, antifungal, antioxidant, antileishmaniatic, antimicrobial, CNS and hypoglycaemic activitiy. Different class of compounds reported from Cassia species are anthraquinones, phenolics, flavonoids, chromenes, terpenes, proanthocyanidins, coumarins, chromones and lignans. The taxonomy and nomenclature of Cassia species are quite complex. It is very difficult to differentiate them due to their overlapping morphological characters and close similarities. This usually leads to misidentification and misinterpretation of the components.

Features:

  • Presents collection of Ayurvedic features and scientific evidence of most important medicinal plants of Cassia species

  • Chemical signatures for identification of Cassia species

  • Easy to use analytical procedure for quality control of Cassia species and its products.


Author: Brijesh Kumar,Vikas Bajpai,Vikaskumar Gond
ISBN-10: 1032030216
ISBN-13: 9781032030210
Publisher: CRC Press
Language: English
Published: 08/12/2021
Pages: 128
Format: Hardcover
Weight: 0.66lbs
Size: 8.50h x 5.50w x 0.38d
By Brijesh Kumar
By Brijesh Kumar
x

Dr. Brijesh Kumar is a retired Professor (AcSIR) and Chief Scientist of Sophisticated Analytical Instrument Facility (SAIF) Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, India. He has completed his M. Sc. from Lucknow University and Ph.D from CSIR-CDRI, Lucknow (Dr. Ram. Manohar. Lohia, Avadh University, Faizabad, UP, India). He has to his credit 7 books, 11 book chapters and 147 papers in reputed international journals. His area of research includes applications of mass spectrometry for qualitative and quantitative analysis of molecules for quality control and authentication/standardization of medicinal plants/parts and their herbal formulations

Vikas Bajpai completed his PhD from the Academy of Scientific and Innovative Research (AcSIR), New Delhi, India and carried his research work under supervision of Dr. Brijesh Kumar at CSIR-Central Drug research Institute Lucknow. His research includes development and validation of LC-MS/MS methods for qualitative and quantitative analysis of small molecules of Indian medicinal plants.

Mr. Vikas Kumar Gond is research fellow worked under supervision of Dr. Brijesh Kumar in mass spectrometry laboratory, sophisticated Analytical Instrument Facility at CSIR-Central Drug research Institute, Lucknow. He completed his masters in pharmaceutical chemistry from university of Lucknow. His research includes fingerprinting and characterization of phytopharmaceuticals using LC-MS/MS methods for qualitative and quantitative screening.

Dr. Subhashis Pal is a biologist, born in 1987 in Kolkata, India. He obtained his doctoral degree in 2019 specializing in Endocrinology and bone biology from Jawaharlal Nehru University, Delhi, India. During his Ph.D. tenure, he worked in Central Drug Research Institute, Lucknow, India on the potential bone anabolic role of phosphodiesterase inhibitors. Dr Pal joined Emory University, Atlanta, USA as staff research associate and currently working at Emory University with the effect of gut microbiome on bone health.

Dr. Naibedya Chattopadhyay is a Chief Scientist at CSIR-Central Drug Research Institute. His areas of research are endocrine pharmacology and metabolic bone diseases. Dr. Chattopadhyay has published >200 research articles and 9 patents out of which 5 are licensed to industries.

Recently Viewed Products